CareLit · DOI-Nachweis · Pneumologie
Final pooled data from Phase II studies (AIRLEAF®, CLAIRLEAF®) of the dipeptidyl peptidase 1 (or Cathepsin C) inhibitor verducatib in bronchiectasis
DOI 10.1055/s-0046-1826158
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Shteinberg, W Sauter, A Eleftheraki, S H Chotirmall, P A Flume, R Jain, K Morimoto, A E O’Donnell, F C Ringshausen, H Watz, J F Xu, J Rauch, O Körsgen, M A Mall, A Gupta, J D Chalmers
ZeitschriftPneumologie
Ausgabe10/2026
Jahrgang / SeitenJg. 80 · S. e73-e74
Kernaussage aus der Literatur
Abstract-Vorschau
Final pooled data from Phase II studies (AIRLEAF®, CLAIRLEAF®) of the dipeptidyl peptidase 1 (or Cathepsin C) inhibitor verducatib in bronchiectasis
Zitieren
Zitierempfehlung
M Shteinberg, W Sauter, A Eleftheraki, S H Chotirmall, P A Flume, R Jain, K Morimoto, A E O’Donnell, F C Ringshausen, H Watz, J F Xu, J Rauch, O Körsgen, M A Mall, A Gupta, J D Chalmers (2026) Final pooled data from Phase II studies (AIRLEAF®, CLAIRLEAF®) of the dipeptidyl peptidase 1 (or Cathepsin C) inhibitor verducatib in bronchiectasis. Pneumologie, 80 (10), e73-e74. https://doi.org/10.1055/s-0046-1826158
Mit CareLit weiterarbeiten